Point72 Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-268,743
Closed -$72.2M 2126
2023
Q3
$72.2M Buy
268,743
+267,033
+15,616% +$66.6M 0.21% 103
2023
Q2
$380K Buy
+1,710
New +$397K ﹤0.01% 1318
2019
Q3
Sell
-1,000
Closed -$184K 1115
2019
Q2
$184K Buy
+1,000
New +$179K ﹤0.01% 981
2017
Q2
Sell
-180,000
Closed -$29.5M 819
2017
Q1
$29.5M Buy
+180,000
New +$29.9M 0.16% 164
2014
Q3
Sell
-238,008
Closed -$28.2M 635
2014
Q2
$28.2M Buy
+238,008
New +$27.6M 0.18% 157

Other funds holding AMGN

Point72 Asset Management's AMGN Position: Q4 2023 in Review

Point72 Asset Management sold out of Amgen (AMGN) in Q4 2023, closing a stake of 268,743 shares — an estimated $72.2M sold.

Point72 Asset Management first reported a position in AMGN in Q2 2014 and held it in 5 quarters. The position peaked at $72.2M in Q3 2023. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Point72 Asset Management reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 268,743 Amgen shares in Q4 2023, an estimated $72.2M.
  • Point72 Asset Management first reported a position in Amgen in Q2 2014 and held it in 5 quarters.
  • Point72 Asset Management's Amgen position peaked at $72.2M in Q3 2023.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.